Symbiotica Speciality Ingredients is a Malaysian-based manufacturer specialising in Active Pharmaceutical Ingredients (API) and adhering to the Pharmaceutical Inspection Cooperation Scheme (PIC/S, Geneva) – ICH Q7 GMP Guidelines. Established in 2001, the company operates a cGMP certified facility located in Kulim, Kedah, with production capacities of 10 metric tonnes per annum for steroidal products and 20 metric tonnes per annum for non-steroidal products. With versatility in synthesis capabilities spanning from gram to kilogram to tonne levels, Symbiotica has successfully undergone inspections by the US FDA, Japanese PMDA, and COFEPRIS Mexico, in addition to routine evaluations from the NPRA, a recognised PIC/S member authority.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– APIs (Active Pharmaceutical Ingredients)
– Biologics
– Biopharmaceuticals
– Contract Development and Manufacturing (CDMO)
– Intermediates
– Fine Chemicals
– Machinery & Equipment

Symbiotica Speciality Ingredients is committed to delivering high-quality products and services to the pharmaceutical industry while maintaining compliance with international standards. To find more information, please visit symbiotica.com.my.